Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability.

Newall AT, Dehollain JP, Creighton P, Beutels P, Wood JG.

Pharmacoeconomics. 2013 Aug;31(8):693-702. doi: 10.1007/s40273-013-0060-7.

PMID:
23645539
2.

Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.

Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dunham KM, Meltzer MI.

PLoS One. 2011;6(7):e22308. doi: 10.1371/journal.pone.0022308. Epub 2011 Jul 29.

3.

Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.

Baguelin M, Camacho A, Flasche S, Edmunds WJ.

BMC Med. 2015 Oct 13;13:236. doi: 10.1186/s12916-015-0452-y.

4.

Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.

Lugnér AK, van Boven M, de Vries R, Postma MJ, Wallinga J.

BMJ. 2012 Jul 12;345:e4445. doi: 10.1136/bmj.e4445.

5.

Estimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in Canada.

Fisman DN, Tuite AR.

PLoS One. 2011;6(11):e27420. doi: 10.1371/journal.pone.0027420. Epub 2011 Nov 14.

6.

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.

Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ.

Vaccine. 2010 Mar 11;28(12):2370-84. doi: 10.1016/j.vaccine.2010.01.002. Epub 2010 Jan 21.

PMID:
20096762
7.

Economic evaluations of childhood influenza vaccination: a critical review.

Newall AT, Jit M, Beutels P.

Pharmacoeconomics. 2012 Aug 1;30(8):647-60. doi: 10.2165/11599130-000000000-00000. Review.

PMID:
22788257
8.

Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model.

Pitman RJ, Nagy LD, Sculpher MJ.

Vaccine. 2013 Jan 30;31(6):927-42. doi: 10.1016/j.vaccine.2012.12.010. Epub 2012 Dec 14.

9.

Under-explored assumptions in influenza vaccination models: implications for the universal vaccination of children.

Newall AT, Dehollain JP, Wood JG.

Vaccine. 2012 Aug 24;30(39):5776-81. doi: 10.1016/j.vaccine.2012.06.067. Epub 2012 Jul 10.

PMID:
22789505
10.

Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR.

Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31. Review.

11.

Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.

Jit M, Newall AT, Beutels P.

Hum Vaccin Immunother. 2013 Apr;9(4):834-40. doi: 10.4161/hv.23637. Epub 2013 Jan 28. Review.

12.

[A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].

Vitale F, Barbieri M, Dirodi B, Vitali Rosati G, Franco E.

Ann Ig. 2013 Jan-Feb;25(1):43-56. doi: 10.7416/ai.2013.1905. Italian.

PMID:
23435779
13.

Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.

Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Møller P, Pedersen MK, Kristiansen IS.

Vaccine. 2006 Jul 17;24(29-30):5690-9. Epub 2006 May 5.

PMID:
16735083
14.

Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.

Nichol KL.

Vaccine. 2011 Oct 6;29(43):7554-8. doi: 10.1016/j.vaccine.2011.08.015. Epub 2011 Aug 4. Review.

PMID:
21820477
15.

Cost-effectiveness of influenza vaccination of healthy children.

Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T.

Vaccine. 2006 Jun 5;24(23):4934-41. Epub 2006 Apr 7.

PMID:
16678945
16.

Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.

Myers ER, Misurski DA, Swamy GK.

Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S128-40. doi: 10.1016/j.ajog.2011.04.009. Epub 2011 Apr 15. Review.

PMID:
21640230
17.

Cost-effectiveness of influenza vaccination in high-risk children in Argentina.

Dayan GH, Nguyen VH, Debbag R, Gómez R, Wood SC.

Vaccine. 2001 Jul 20;19(30):4204-13.

PMID:
11457546
18.

The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age.

Turner DA, Wailoo AJ, Cooper NJ, Sutton AJ, Abrams KR, Nicholson KG.

Vaccine. 2006 Feb 13;24(7):1035-43. Epub 2005 Sep 6.

PMID:
16183177
19.

Influenza cost and cost-effectiveness studies globally--a review.

Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson MA.

Vaccine. 2013 Nov 4;31(46):5339-48. doi: 10.1016/j.vaccine.2013.09.013. Epub 2013 Sep 19. Review.

PMID:
24055351
20.

Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age.

Marchetti M, Kühnel UM, Colombo GL, Esposito S, Principi N.

Hum Vaccin. 2007 Jan-Feb;3(1):14-22. Epub 2007 Jan 29.

PMID:
17245134
Items per page

Supplemental Content

Write to the Help Desk